Insiders · Profile

Jayne David R.W.

Director at Aurinia Pharmaceuticals. Filing since 23 May 2023. CIK 0001838242

Company
Date
Role
Action
Shares
Amount
Of holding
21 May 2024
Director
Sold at will
4,946
$28.39K
10.0%
23 May 2023
Director
Sold at will
8,733
$98.33K
15.0%
2 decisions on file.